Johnson & Johnson (JNJ)

127.73
NYSE : Health Technology
Prev Close 131.27
Day Low/High 127.13 / 131.26
52 Wk Low/High 121.00 / 148.99
Avg Volume 7.29M
Exchange NYSE
Shares Outstanding 2.64B
Market Cap 346.44B
EPS 5.70
P/E Ratio 21.77
Div & Yield 3.80 (2.78%)
3 Stocks That Would Be Hurt by a Strong Dollar

3 Stocks That Would Be Hurt by a Strong Dollar

3M, Caterpillar and Johnson & Johnson all face headwinds with a strong dollar.

Charts of Alcon Look Good

Charts of Alcon Look Good

Traders could go long on the eye-care company on strength above $62 risking below $59 with a $72 price target.

Jim Cramer: Looking for Netflix Action? Don't Be a Hero

Jim Cramer: Looking for Netflix Action? Don't Be a Hero

Stranger things have happened, but with NFLX's subscriber miss, the stock just became hard money, joining the likes of Johnson & Johnson and CSX Corp.

Small Caps Rise as Traders Change Channel on NFLX, Other Big Caps

Small Caps Rise as Traders Change Channel on NFLX, Other Big Caps

It's a stock picker's market as action in individual stocks is better than on the indexes.

Complacent Market Players Keep It Chill -- as Sparks Fly All 'Round

Complacent Market Players Keep It Chill -- as Sparks Fly All 'Round

It is still a surprisingly sedate market, despite indexes sitting close to all-time highs, earnings season, possible interest-rate cuts and endless speculation about China trade.

Markets' Health, Facebook Libra Hearings, Trading Match Group: Market Recon

Markets' Health, Facebook Libra Hearings, Trading Match Group: Market Recon

For those trading the FANG or FAANG names, and especially Facebook, Tuesday sets up as a day bearing exceptional levels of headline risk.

This Sedate Market Is an Ink Blot Test for Investors

This Sedate Market Is an Ink Blot Test for Investors

The bulls will say this is healthy consolidation that will set up another leg higher, while the bears will say this is an indication of indecision and is a prelude to a rollover.

Jim Cramer: Don't Play Earnings Season, Invest in It

Jim Cramer: Don't Play Earnings Season, Invest in It

Here are my five rules for handling earnings season.

Johnson & Johnson: Key Points to Watch on the Charts

Johnson & Johnson: Key Points to Watch on the Charts

The stock has been bouncing off the 200-day moving average line.

10 Stocks and 10 ETFs for Socially Conscious Investors

10 Stocks and 10 ETFs for Socially Conscious Investors

Investors have shown an increasing interest in ESG Investing. These top investment vehicles emphasize strong business operations and social responsibilities.

Jim Cramer: A Tale of Two Stocks

Jim Cramer: A Tale of Two Stocks

I want you to remember Eli Lilly and Johnson & Johnson the next time you are about to dump a stock because of some bits of bad news.

Jim Cramer: This Is Now an Emotional Market

Jim Cramer: This Is Now an Emotional Market

When traders are flailing and investors are drowning, examples work best to illustrate what happens before a bottom is reached.

Band-Aids Cannot Help Johnson & Johnson in This Decline

Band-Aids Cannot Help Johnson & Johnson in This Decline

Let's take a serious look at the charts and indicators.

Water Company Dividend Kings That Quench the Thirst for Income

Water Company Dividend Kings That Quench the Thirst for Income

Dividend stock investors should look to have at least some exposure to this sector.

Jim Cramer: What to Buy and What to Avoid on Trump's Latest China Tweet

Jim Cramer: What to Buy and What to Avoid on Trump's Latest China Tweet

As usual, the stocks that bounce back first are the tech stocks with little Chinese exposure and the consumer packaged goods that just demonstrated good numbers.

Be Careful With Healthcare Stocks Here

Be Careful With Healthcare Stocks Here

Especially when healthcare CEOs discus political issues with analysts and reporters.

Johnson & Johnson and United Healthcare Face a Series of Obstacles

Johnson & Johnson and United Healthcare Face a Series of Obstacles

Recapping a big day of earnings for both names.

Fibocall: Tuesday Early Texts

Fed's Evans Knows Nothing, China Q1 GDP, Trading Netflix: Market Recon

Fed's Evans Knows Nothing, China Q1 GDP, Trading Netflix: Market Recon

When Netflix reports earnings tonight, what will likely matter above all else for now will be subscriber growth.

How to Trade Johnson & Johnson During Earnings Week

How to Trade Johnson & Johnson During Earnings Week

The biggest challenge is even if JNJ beats and raises guidance, the overhang of litigation could still prevent overzealous trading.

Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Johnson & Johnson or Pfizer: Which Big Pharma Dividend Stock Is a Better Buy?

Healthcare giants Johnson & Johnson and Pfizer offer a tough choice for dividend investors seeking the best returns.

More Mud on Johnson & Johnson?

More Mud on Johnson & Johnson?

There's been enough news with the lawsuits around this name to get the emotion back into the stock. Emotion often leads to volatility.

Jim Cramer: The Fed's Dramatic Sea Change and What It Means for Stocks Now

Jim Cramer: The Fed's Dramatic Sea Change and What It Means for Stocks Now

The best stocks to buy in this environment are the ones that have the greatest growth.

How to Play the Fed's Gift to the Markets (One Way Is With Netflix)

How to Play the Fed's Gift to the Markets (One Way Is With Netflix)

Wednesday was the first day that Netflix traded on above-average volume since Jan. 24.

The Rally in Johnson & Johnson Looks Like it has Run Its Course

The Rally in Johnson & Johnson Looks Like it has Run Its Course

Let's check out the charts.

Jim Cramer: 5 Examples Show Why Stock Investing Is So Difficult

Jim Cramer: 5 Examples Show Why Stock Investing Is So Difficult

Consider these five, right in front of you on this one day, so you get the perils of stock ownership and know how to handle them when they occur.

Digging Down on the Dow 30

Digging Down on the Dow 30

Just 13 of the 30 Dow components are in clear uptrends.

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

Jim Cramer: AAPL Should Get Into Diabetes Treatment and KHC Should Invest in Pot

In this day and age, companies must be 'disruptors' or get left in the dust.

Jim Cramer: The Real Lesson of the 10-Year Bull Market Anniversary

Jim Cramer: The Real Lesson of the 10-Year Bull Market Anniversary

Did the Fed aid Microsoft? No, Microsoft aided Microsoft. J&J aided J&J. Procter aided Procter.

Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

Jim Cramer: No Room for Cynicism, JNJ's New Depression Drug Is Lifesaving

The approval of esketamine, known as Spravato, for use against severe depression is special -- it is saving lives.